Popular Weight-Loss Drugs Not Linked to Higher Risks of Suicidality, but Small Caveat: Study

Published on July 15, 2024

A study published Monday in Annals of Internal Medicine found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of popular weight-loss and Type 2 diabetes drugs, are not linked to higher risks of suicidal ideation and behaviors. The study involved older patients taking the drug for diabetes. “Basically, our study didn’t show any significant concern regarding suicide [and suicidality],” Dr. Serena Jingchuan Guo, the study’s senior author and assistant professor of pharmacy at the University of Florida, told The Epoch Times. However, she added that the study did not evaluate patients who took the drug for obesity or follow younger patients. Therefore, her findings could not be applied to these populations....